Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5197]

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and...

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia,

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia, )

Evaluation and definition of response and progression from trials to clinical...

Dr Andrew Armstrong - Duke University, Durham, North Carolina

Evaluation and definition of response and progression from trials to clinical practice ( Dr Andrew Armstrong - Duke University, Durham, North Carolina )

FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA

FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle...

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )

Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or...

Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA

$Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma ( Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA )$

Climate and environmental factors drive seasonal risk of invasive mucormycosis...

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA

Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )

Extreme heat exposure around diagnosis is linked to higher mortality in...

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA

Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC ( Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA )

Innovating cancer care access for low and middle-income countries

Lacy Hubbard - Founding President and CEO, Elekta Foundation

Innovating cancer care access for low and middle-income countries ( Lacy Hubbard - Founding President and CEO, Elekta Foundation )

Empowering Caribbean and African communities to take charge of cancer prevention

Prof Faye Ruddock - Chair & Founder, Caribbean & African Health Network (CAHN)

Empowering Caribbean and African communities to take charge of cancer prevention ( Prof Faye Ruddock - Chair & Founder, Caribbean & African Health Network (CAHN) )

What are the barriers for diverse and inclusive clinical trial recruitment?

Prof Sheeba Irshad - King's College London, London, UK

What are the barriers for diverse and inclusive clinical trial recruitment? ( Prof Sheeba Irshad - King's College London, London, UK )

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD...

Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform ( Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA )

More from ecancer